Company intelligence / Profile preview

江苏德迈药业

Taizhou, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

Jiangsu Demai Pharmaceutical is a biopharmaceutical company based in the China Medical City of Taizhou, Jiangsu. The company specializes in the research, development, and manufacturing of innovative small molecule drugs and high-end generic medications. Its primary therapeutic focus areas include oncology, cardiovascular diseases, and metabolic disorders. Demai Pharmaceutical operates integrated R&D and manufacturing facilities that adhere to GMP standards. The company is dedicated to providing high-quality, cost-effective therapeutic options to the Chinese healthcare market. It is recognized as a high-tech enterprise within the regional pharmaceutical cluster.

Therapeutic areas: CardiovascularOncologyMetabolic Disorders
Modalities: Small molecule
Industry: Pharma

Drug pipeline

1 asset

DMI019

Unknown

Beyond the preview

Go deeper on 江苏德迈药业.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 江苏德迈药业.

Explore the full profile